OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

TEIJIN LTD/  JP3544000007  /

TradeGate
7/16/2024  9:30:23 AM Chg. -0.10 Volume Bid11:57:34 AM Ask11:57:34 AM Market Capitalization Dividend Y. P/E Ratio
7.75EUR -1.27% 1
Turnover: 7.75		 7.75Bid Size: 646 7.90Ask Size: 632 1.51 bill.EUR - -
TeleTrader 5/31 Blackstone reportedly to buy Japan's Infocom for $1.7B
GlobeNewswire 5/13 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparath...
GlobeNewswire 5/9 Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with...
GlobeNewswire 2/14 Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
GlobeNewswire 2/7 Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire 1/31 Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for ...
GlobeNewswire 1/7 Ascendis Pharma Introduces Vision 2030
GlobeNewswire 12/4/2023 NeuroStar TMS Receives Expanded Regulatory Approval in Japan
GlobeNewswire 11/29/2023 Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan
GlobeNewswire 8/30/2023 Churchill Franklin Automotive Launches Airbag Alert News Service
Newsfile Corp 11/21/2022 The "Electrification" of the World: Battery Safety and Efficiency Demands Grow Amidst Lofty Global E...
GlobeNewswire 2/24/2022 Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
GlobeNewswire 12/20/2021 CORRECTION - MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 12/20/2021 MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 6/2/2021 Radius Health Business Update
GlobeNewswire 3/25/2021 Calling Early Stage Medtech Start Ups: Apply Now for 2021 IGNITE
GlobeNewswire 3/24/2021 Radius Health Provides Update on Abaloparatide
GlobeNewswire 2/25/2021 Radius Health, Inc.: Fourth Quarter and Full Year Results
GlobeNewswire 2/12/2021 Radius Health, Inc. Provides Abaloparatide Business Update
GlobeNewswire 11/5/2020 Radius Health, Inc.: Third Quarter 2020 Operating Results
GlobeNewswire 10/21/2020 Radius Health, Inc.: Progress Since May 2020
GlobeNewswire 9/21/2020 NeuroSigma Receives Bridge Financing from Checkmate Capital
GlobeNewswire 9/9/2020 Radius Health Announces Scientific Presentations on abaloparatide at ASBMR 2020 Annual Meeting
GlobeNewswire 8/10/2020 Radius Health Announces Second Quarter 2020 Operating Results
GlobeNewswire 5/27/2020 Pivotal Phase III trial of abaloparatide-SC in Japanese women and men with osteoporosis achieves pri...